J-code: Drugs administered other than oral method; chemotherapy drugs Drugs administered other than oral method; chemotherapy drugs
1,255 codes
Billing context
J-codes are permanent national codes for drugs and biologicals — most often clinician-administered (buy-and-bill) products paid under Medicare Part B — plus certain immunosuppressive, inhalation (via DME), and oral anticancer/antiemetic drugs. Units are reported in multiples of the dosage in the code descriptor.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| J7110 | Infusion, dextran 75, 500 ml | — | Jan 1, 1982 | Active |
| J7120 | Ringers lactate infusion, up to 1000 cc | $2.369per 1000 CC | Jan 1, 1982 | Active |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | — | Jan 1, 2016 | Active |
| J7131 | Hypertonic saline solution, 1 ml | — | Jan 1, 2012 | Active |
| J7165 | Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity | — | Apr 1, 2024 | Active |
| J7168 | Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity | — | Jul 1, 2021 | Active |
| J7169 | Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg | — | Jul 1, 2020 | Active |
| J7170 | Injection, emicizumab-kxwh, 0.5 mg | $58.114per 0.5 MG | Jan 1, 2019 | Active |
| J7171 | Injection, adamts13, recombinant-krhn, 10 iu | $36.378per 10 UNITS | Jul 1, 2024 | Active |
| J7172 | Injection, marstacimab-hncq, 0.5 mg | $50.760per 0.5 MG | Jul 1, 2025 | Active |
| J7173 | Injection, concizumab-mtci, 0.5 mg | $84.782per 0.5 MG | Oct 1, 2025 | Active |
| J7174 | Injection, fitusiran, 0.04 mg | $133.477per 0.04 MG | Oct 1, 2025 | Active |
| J7175 | Injection, factor x, (human), 1 i.u. | $9.953per 1 IU | Jan 1, 2017 | Active |
| J7176 | Injection, human fibrinogen - chmt (fesilty), 1 mg | — | Jul 1, 2026 | Active |
| J7177 | Injection, human fibrinogen concentrate (fibryga), 1 mg | $1.219per 1 MG | Jan 1, 2019 | Active |
| J7178 | Injection, human fibrinogen concentrate, not otherwise specified, 1 mgNOC / NOS | $1.428per 1 MG | Jan 1, 2013 | Active |
| J7179 | Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco | $1.826per 1 IU | Jan 1, 2017 | Active |
| J7180 | Injection, factor xiii (antihemophilic factor, human), 1 i.u. | $11.239per 1 IU | Jan 1, 2012 | Active |
| J7181 | Injection, factor xiii a-subunit, (recombinant), per iu | $19.328per 1 IU | Jan 1, 2015 | Active |
| J7182 | Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu | $1.557per 1 IU | Jan 1, 2015 | Active |
| J7183 | Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco | $1.304per 1 I.U. VWF:RCO | Jan 1, 2012 | Active |
| J7185 | Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. | $1.369per 1 IU | Jan 1, 2010 | Active |
| J7186 | Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u. | $1.267per PER FACTOR VIII IU | Jan 1, 2009 | Active |
| J7187 | Injection, von willebrand factor complex (humate-p), per iu vwf:rco | $1.531per 1 IU | Jan 1, 2007 | Active |
| J7188 | Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. | $3.236per 1 IU | Jan 1, 2016 | Active |
| J7189 | Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram | $2.774per 1 MCG | Jan 1, 2006 | Active |
| J7190 | Factor viii (antihemophilic factor, human) per i.u. | $1.248per 1 IU | Jan 1, 1986 | Active |
| J7191 | Factor viii (antihemophilic factor (porcine)), per i.u. | — | Jan 1, 1996 | Active |
| J7192 | Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specifiedNOC / NOS | $1.616per 1 IU | Jan 1, 1994 | Active |
| J7193 | Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. | $1.412per 1 IU | Jan 1, 2002 | Active |
| J7194 | Factor ix, complex, per i.u. | $1.748per 1 IU | Jan 1, 1986 | Active |
| J7195 | Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specifiedNOC / NOS | $1.868per 1 IU | Jan 1, 2002 | Active |
| J7196 | Injection, antithrombin recombinant, 50 i.u. | — | Jan 1, 2011 | Active |
| J7197 | Antithrombin iii (human), per i.u. | $4.264per 1 IU | Jan 1, 1992 | Active |
| J7198 | Anti-inhibitor, per i.u. | $2.474per 1 IU | Jan 1, 2000 | Active |
| J7199 | Hemophilia clotting factor, not otherwise classifiedNOC / NOS | — | Jan 1, 2000 | Active |
| J7200 | Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu | $1.713per 1 IU | Jan 1, 2015 | Active |
| J7201 | Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. | $3.761per 1 IU | Jan 1, 2015 | Active |
| J7202 | Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. | $5.491per 1 IU | Jan 1, 2017 | Active |
| J7203 | Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu | $4.715per 1 IU | Jan 1, 2019 | Active |
| J7204 | Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu | $2.363per 1 IU | Jul 1, 2020 | Active |
| J7205 | Injection, factor viii fc fusion protein (recombinant), per iu | $2.557per 1 IU | Jan 1, 2016 | Active |
| J7207 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. | $2.185per 1 IU | Jan 1, 2017 | Active |
| J7208 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. | $2.744per 1 IU | Jul 1, 2019 | Active |
| J7209 | Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. | $1.179per 1 IU | Jan 1, 2017 | Active |
| J7210 | Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. | $1.612per 1 IU | Jan 1, 2018 | Active |
| J7211 | Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. | $1.574per 1 IU | Jan 1, 2018 | Active |
| J7212 | Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram | $2.250per 1 MCG | Jan 1, 2021 | Active |
| J7213 | Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. | $2.035per 1 IU | Jul 1, 2023 | Active |
| J7214 | Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. | $4.656per 1 IU | Oct 1, 2023 | Active |
| J7294 | Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each | — | Oct 1, 2021 | Active |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | — | Oct 1, 2021 | Active |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | — | Jan 1, 2018 | Active |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | — | Jan 1, 2016 | Active |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | — | Jan 1, 2016 | Active |
| J7299 | Intrauterine copper contraceptive (miudella) | — | Jan 1, 2026 | Active |
| J7300 | Intrauterine copper contraceptive (paragard) | — | Jan 1, 1986 | Active |
| J7301 | Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg | — | Jan 1, 2014 | Active |
| J7302 | Levonorgestrel-releasing intrauterine contraceptive system, 52 mg | — | Jan 1, 2002 | Ended Dec 31, 2015 |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | — | Jan 1, 2004 | Ended Sep 30, 2021 |
| J7304 | Contraceptive supply, hormone containing patch, each | — | Jan 1, 2005 | Active |
| J7306 | Levonorgestrel (contraceptive) implant system, including implants and supplies | — | Jan 1, 2006 | Active |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | — | Jan 1, 2008 | Active |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | $390.523per 354 MG | Jan 1, 2002 | Active |
| J7309 | Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram | — | Jan 1, 2011 | Ended Dec 31, 2025 |
| J7310 | Ganciclovir, 4.5 mg, long-acting implant | — | Jan 1, 1997 | Ended Dec 31, 2025 |
| J7311 | Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg | $341.131per 0.01 MG | Jan 1, 2007 | Active |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | $202.424per 0.1 MG | Jan 1, 2011 | Active |
| J7313 | Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg | $516.516per 0.01 MG | Jan 1, 2016 | Active |
| J7314 | Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg | — | Oct 1, 2019 | Active |
| J7315 | Mitomycin, ophthalmic, 0.2 mg | — | Jan 1, 2013 | Active |
| J7316 | Injection, ocriplasmin, 0.125 mg | — | Jan 1, 2014 | Active |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | $6.314per 1 MG | Jan 1, 2019 | Active |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | $4.231per 1 MG | Jan 1, 2017 | Active |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | $69.868per per dose | Jan 1, 2008 | Active |
| J7322 | Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg | $17.940per 1 MG | Jan 1, 2017 | Active |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | $103.603per per dose | Jan 1, 2008 | Active |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | $116.793per PER DOSE | Jan 1, 2008 | Active |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | $6.011per 1 MG | Jan 1, 2010 | Active |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | $524.063per per dose | Jan 1, 2012 | Active |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | $626.144per PER DOSE | Jan 1, 2015 | Active |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | $0.550per 0.1 MG | Jan 1, 2016 | Active |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | $4.207per 1 MG | Jan 1, 2019 | Active |
| J7330 | Autologous cultured chondrocytes, implant | — | Jan 1, 2001 | Active |
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | $3.115per 1 MG | Oct 1, 2019 | Active |
| J7332 | Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | $10.188per 1 MG | Oct 1, 2019 | Active |
| J7333 | Hyaluronan or derivative, visco-3, for intra-articular injection, per dose | — | Jul 1, 2020 | Ended Mar 31, 2021 |
| J7335 | Capsaicin 8% patch, per 10 square centimeters | — | Jan 1, 2011 | Ended Dec 31, 2014 |
| J7336 | Capsaicin 8% patch, per square centimeter | $3.509per 1 SQ CM | Jan 1, 2015 | Active |
| J7340 | Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml | $243.108per 100 ML | Jan 1, 2016 | Active |
| J7342 | Instillation, ciprofloxacin otic suspension, 6 mg | — | Jan 1, 2017 | Active |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | $1.848per 10 MG | Jan 1, 2018 | Active |
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | $213.795per 1 MCG | Oct 1, 2020 | Active |
| J7352 | Afamelanotide implant, 1 mg | — | Jan 1, 2021 | Active |
| J7353 | Anacaulase-bcdb, 8.8% gel, 1 gram | — | Oct 1, 2023 | Active |
| J7354 | Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) | $683.472per Per 3.2 mg single-use applicator | Apr 1, 2024 | Active |
| J7355 | Injection, travoprost, intracameral implant, 1 microgram | $196.804per 1 MCG | Jul 1, 2024 | Active |
| J7356 | Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg | $0.702per 0.25 MG - 5 MG | Jul 1, 2025 | Active |
| J7401 | Mometasone furoate sinus implant, 10 micrograms | — | Oct 1, 2019 | Ended Mar 31, 2021 |
| J7402 | Mometasone furoate sinus implant, (sinuva), 10 micrograms | $11.345per 10 MCG | Apr 1, 2021 | Active |